Citizens JMP Reiterates Market Outperform Rating on Acadia Pharmaceuticals (ACAD)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 21.88 +0.41 (1.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.47 | 52 Week High | $42.49 | |||
| Open | $21.98 | 52 Week Low | $16.64 | |||
| Day High | $22.15 | P/E | N/A | |||
| Day Low | $21.33 | EPS | $-0.42 | |||
| Volume | 625,732 | |||||
